The air in the meeting room of Ruixing Medical Technology Company seemed to have solidified.
Every executive present understood—the success or failure of Professor Yang Ping's project was not only about the life or death of a research project but also determined whether China's biomedical industry could break free from being constrained by foreign core tools and underlying technologies.
This was both a crisis and an opportunity!
"We cannot let Professor Yang fight alone." Although Huang Jiacai's voice was not loud, every word hit home like iron, "What they are blocking is not just a project group but the future of our entire industry's upgrade. We must retaliate—in our own way."
He stood up and walked towards a huge electronic screen, and a complex map of high-end experimental equipment and reagent supply chains slowly unfolded.
